Pharmaceuticals

Angioedema Treatment Market Future Outlook 2026: Key Drivers and Growth Potential

February 12, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the angioedema treatment market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Angioedema Treatment Market?

The angioedema treatment market has seen substantial expansion in recent years. This market is set to increase from $3.13 billion in 2025 to $3.59 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.8%. Factors contributing to its historical growth include the necessity for emergency allergy management, prevalent hospital-based care, the use of corticosteroids, the accessibility of antihistamines, and the restricted availability of highly targeted medications.

The angioedema treatment market is projected to experience substantial growth over the coming years, reaching a valuation of $6.18 billion by 2030, driven by a compound annual growth rate (CAGR) of 14.5%. This anticipated expansion throughout the forecast period stems from factors such as the advancement of biologic drugs, an increase in genetic testing, the proliferation of specialty allergy clinics, enhanced patient education, and a heightened focus on preventive care. Key trends anticipated during this period encompass a greater adoption of targeted bradykinin therapies, the expansion of hereditary angioedema treatments, the broader implementation of emergency treatment protocols, enhanced awareness in diagnostics, and a continued emphasis on preventive therapies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24460&type=smp

What Drivers Are Supporting Technological Adoption In The Angioedema Treatment Market?

The angioedema treatment market is projected to expand due to an increasing occurrence of rare diseases. These are defined as medical conditions impacting a very small segment of the population, often characterized by few treatment choices and substantial health effects. The rise in rare disease cases is attributed to progress in genetic testing and diagnostic technologies, which allow healthcare providers to identify and precisely diagnose conditions previously missed, thereby increasing their reported prevalence. Angioedema treatment benefits rare conditions like hereditary angioedema by offering specific therapies that help prevent and control severe swelling episodes, thus enhancing patient results. For example, in November 2024, the Food and Drug Administration, a US-based federal agency, reported that more than 7,000 rare diseases affected over 30 million individuals in the United States. Consequently, the growing incidence of rare diseases is fueling the expansion of the angioedema treatment market.

Which Segments Are Contributing To The Growth Of The Angioedema Treatment Market?

The angioedema treatment market covered in this report is segmented –

1) By Type: Allergic Angioedema, Drug-Induced Angioedema, Idiopathic Angioedema, Hereditary Angioedema

2) By Route Of Administration: Injection, Oral

3) By End Use: Hospitals, Clinics, Research Organizations

Subsegments:

1) By Allergic Angioedema: Antihistamines, Corticosteroids, Epinephrine, Immunotherapy, Allergen Avoidance Therapies

2) By Drug-Induced Angioedema: Discontinuation of Causative Drug, Antihistamines, Corticosteroids, Epinephrine, Bradykinin Pathway Inhibitors

3) By Idiopathic Angioedema: Empirical Antihistamine Therapy, Corticosteroid Therapy, Leukotriene Receptor Antagonists, Monoclonal Antibodies, Observation and Symptom Management

4) By Hereditary Angioedema: C1 Esterase Inhibitor Replacement Therapy, Bradykinin B2 Receptor Antagonists, Kallikrein Inhibitors, Attenuated Androgens, Antifibrinolytics

Which Trends Are Guiding The Evolution Of The Angioedema Treatment Market?

Leading companies within the angioedema treatment market are dedicating efforts to developing inventive solutions, including subcutaneous injections, aiming to provide enhanced convenience and quicker alleviation for individuals experiencing acute hereditary angioedema (HAE) attacks. This method involves administering medication into the fatty tissue directly under the skin, facilitating a gradual and consistent absorption into the bloodstream. For example, in April 2025, CSL Limited, an Australia-based biotechnology company, introduced ANDEMBRY (garadacimab). This product serves as a novel, fully human monoclonal antibody treatment designed to prevent acute attacks in patients with hereditary angioedema (HAE). ANDEMBRY distinguishes itself as the inaugural pre-filled pen engineered for once-monthly subcutaneous administration, thereby presenting a practical long-term prophylactic choice. Its mechanism of action involves inhibiting activated Factor XII (Factor XIIa), a critical initiator in the biochemical cascade that results in angioedema. This represents a notable progression in HAE management, delivering effective and patient-centric control of the condition.

Who Are The Major Companies Operating In The Angioedema Treatment Market?

Major companies operating in the angioedema treatment market are Sanofi SA, Takeda Pharmaceutical Company Limited, Viatris Inc., Otsuka Pharmaceutical Co. Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd, Cipla Inc., Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals Inc., Salix Pharmaceuticals Ltd, BioCryst Pharmaceuticals Inc., Pharming Group NV, Pharvaris Netherlands B.V, Astria Therapeutics, Intellia Therapeutics, KalVista Pharmaceuticals Ltd., ADARx Pharmaceuticals, Adverum Biotechnologies Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/angioedema-treatment-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Angioedema Treatment Market?

North America was the largest region in the angioedema treatment market in 2025. The regions covered in the angioedema treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Angioedema Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24460&type=smp

Browse Through More Reports Similar to the Global Angioedema Treatment Market 2026, By The Business Research Company

Hereditary Angioedema Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/hereditary-angioedema-therapeutics-global-market-report

Retinal Vein Occlusion Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/retinal-vein-occlusion-treatment-global-market-report

Angina Pectoris Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795